EDBI Pte Ltd
- SEC CIK
- 0001913506
- Latest filing
- Feb 4, 2025
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 7, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 17
- +2 vs. Q1 2024
- Portfolio value
- $88.4M
- −$454.4K (−0.5%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SNOWSnowflake Inc. | Stock | 145,009 | $19.6M | 22.1% | 00.0% | Unchanged | History |
| JOBYJoby Aviation, Inc. | COMMON STOCK | 3,004,549 | $15.3M | 17.3% | 00.0% | Unchanged | History |
| CXMSprinklr, Inc. | CL A | 1,110,777 | $10.7M | 12.1% | 00.0% | Unchanged | History |
| Walkme LtdM97628107 | ORD SHS | 761,864 | $10.6M | 12.0% | 00.0% | Unchanged | – |
| GRABGrab Holdings Ltd | CLASS A ORD | 2,822,035 | $10.0M | 11.3% | 00.0% | Unchanged | History |
| AVPTAvePoint, Inc. | COM CL A | 700,000 | $7.29M | 8.2% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 1,270,504 | $3.71M | 4.2% | 00.0% | Unchanged | History |
| DDOGDatadog, Inc. | CL A COM | 19,078 | $2.47M | 2.8% | +3,454+22.1% | Added | History |
| ERASErasca, Inc. | COM | 888,888 | $2.10M | 2.4% | 00.0% | Unchanged | History |
| PLPlanet Labs PBC | COM CL A | 1,065,593 | $1.98M | 2.2% | 00.0% | Unchanged | History |
| MQMarqeta, Inc. | CLASS A COM | 255,753 | $1.40M | 1.6% | 00.0% | Unchanged | History |
| OSCROscar Health, Inc. | CL A | 60,740 | $960.9K | 1.1% | +60,740 | New | History |
| BRZEBraze, Inc. | Stock | 15,836 | $615.1K | 0.7% | +15,836 | New | History |
| GTLBGitlab Inc. | CLASS A COM | 11,973 | $595.3K | 0.7% | +5,807+94.2% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 10,105 | $461.8K | 0.5% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 222,136 | $371.0K | 0.4% | 00.0% | Unchanged | History |
| HCPHashiCorp, Inc. | COM CL A | 6,500 | $219.0K | 0.2% | +6,500 | New | History |
Sold out since Q1 2024 (1)
Positions held at the end of Q1 2024 that are gone from this filing.